发明名称 |
METHOD OF INHIBITING MUTANT C-KIT |
摘要 |
The present invention includes a method of reducing or inhibiting the kinase activity of C-KIT mutant tyrosine kinase activity in a cell or a subject, and the use of such compound for treating mutant C-KIT driven cell proliferative disorder(s) in a subject related to using a compound of the present invention:;;or pharmaceutically acceptable salt thereof. |
申请公布号 |
US2016367545(A1) |
申请公布日期 |
2016.12.22 |
申请号 |
US201615255912 |
申请日期 |
2016.09.02 |
申请人 |
Arog Pharmaceuticals, LLC |
发明人 |
Jain Vinay K. |
分类号 |
A61K31/4709 |
主分类号 |
A61K31/4709 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inhibiting or reducing mutant C-KIT tyrosine kinase activity or expression in a subject suffering from a proliferative disease which comprises administering to the subject having or suspected to have the proliferative disease, a therapeutically effective amount of the compound of Formula I:or a pharmaceutically acceptable salt or solvate thereof. |
地址 |
Dallas TX US |